Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.1.1.69 (
BMT
)
2,655
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We investigated the role of polymorphism of the
vitamin D receptor
(
VDR
) gene in HLA-matched sibling
BMT
for polymorphisms previously associated with human disease pathology. In intron 8 of the
VDR
gene, the B and A alleles of the BsmI and ApaI RFLPs were found to associate with reduced aGVHD when present in the patient's genotype. Logistic regression analysis demonstrated that patient
VDR
genotype, along with previously identified IL-10(-1064) and IFN-gamma genotype to be risk factors for severe acute GVHD. The A allele also associates with increased likelihood of death when present in the donor genotype (AA vs Aa or aa, hazard ratio 2.03, P = 0.0232). In patients who received increased prophylaxis with multi-agent therapy, patients whose graft was from a donor with an AA genotype had a substantially worse survival than patients whose graft was from a donor with a non-AA genotype (hazard ratio 12.93, P < 0.0001). Analysis of
VDR
genotype in prospective
BMT
recipients could indicate patients at risk of severe aGVHD. Analysis of
VDR
genotype in prospective
BMT
donors may identify individuals who have greater transplant-related mortality, and also allow appropriately restricted use of increased immunosuppressive prophylaxis.
...
PMID:Vitamin D receptor gene polymorphism associates with graft-versus-host disease and survival in HLA-matched sibling allogeneic bone marrow transplantation. 1220 38
Although vitamin D has been implicated in cardiovascular protection, few studies have addressed the role of
vitamin D receptor
(
VDR
) in atherosclerosis. Here we investigate the effect of inactivation of the
VDR
signaling on atherogenesis and the antiatherosclerotic mechanism of vitamin D. Low density lipoprotein receptor (LDLR)(-/-)/
VDR
(-/-) mice exhibited site-specific accelerated atherogenesis, accompanied by increases in adhesion molecules and proinflammatory cytokines in the aorta and cholesterol influx in macrophages. Macrophages showed marked renin up-regulation in the absence of
VDR
, and inhibition of renin by aliskiren reduced atherosclerosis in LDLR(-/-)/
VDR
(-/-) mice, suggesting that the renin-angiotensin system (RAS) promotes atherosclerosis in the absence of
VDR
. LDLR(-/-) mice receiving LDLR(-/-)/
VDR
(-/-)
BMT
developed larger lesions than LDLR(-/-)
BMT
controls. Moreover, LDLR(-/-) mice receiving Rag-1(-/-)/
VDR
(-/-)
BMT
, which were unable to generate functional T and B lymphocytes, still had more severe atherosclerosis than Rag-1(-/-)
BMT
controls, suggesting a critical role of macrophage
VDR
signaling in atherosclerotic suppression. Aliskiren treatment eliminated the difference in lesions between Rag-1(-/-)/
VDR
(-/-)
BMT
and Rag-1(-/-)
BMT
recipients, indicating that local RAS activation in macrophages contributes to the enhanced atherogenesis seen in Rag-1(-/-)/
VDR
(-/-)
BMT
mice. Taken together, these observations provide evidence that macrophage
VDR
signaling, in part by suppressing the local RAS, inhibits atherosclerosis in mice.
...
PMID:Vitamin D receptor signaling inhibits atherosclerosis in mice. 2263 71